Meanwhile, the BSE Sensex was down 47.89 points, or 0.21%, to 22,503.60.

On BSE, so far 284 shares were traded in the counter, compared with an average volume of 15,685 shares in the past one quarter.

The stock hit a high of Rs 2,584.80 and a low of Rs 2,558.90 so far during the day. The stock hit a record high of Rs 3,054.40 on 3 March 2014. The stock hit a 52-week low of Rs 2,155 on 29 April 2013.

The stock had underperformed the market over the past one month till 2 April 2014, falling 14.69% compared with the Sensex's 6.78% rise. The scrip had also underperformed the market in past one quarter, falling 13.02% as against Sensex's 7.96% rise.

The large-cap company has an equity capital of Rs 84.70 crore. Face value per share is Rs 10.

Before turning ex-dividend, the stock offered a dividend yield of 1.92% based on the closing price of Rs 2,598.55 on Wednesday, 2 April 2014.

GlaxoSmithkline Pharmaceuticals' (GSK Pharma) net profit fell 15.61% to Rs 116.88 crore on 1.5% decline in total income to Rs 693.45 in Q4 December 2013 over Q4 December 2012.

GSK Pharma is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular diseases and respiratory diseases.